These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 36301313

  • 21. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V, Gartenmann S, Tötzl M, Lucchini V, Schellhorn B, Pieren M, Lociuro S, Gitzinger M, Tigges M, Bumann D, Kemmer C.
    mBio; 2019 Jul 16; 10(4):. PubMed ID: 31311879
    [Abstract] [Full Text] [Related]

  • 22. Exploring the Correlation of Dynamic Surface Tension with Antimicrobial Activities of Quaternary Ammonium-Based Disinfectants.
    Vargas-Cuebas GG, Sanchez CA, Brayton SR, Nikoloff A, Masters R, Minbiole KPC, Wuest WM.
    ChemMedChem; 2024 Aug 19; 19(16):e202400262. PubMed ID: 38718280
    [Abstract] [Full Text] [Related]

  • 23. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC.
    Microb Pathog; 2019 Mar 19; 128():75-81. PubMed ID: 30562602
    [Abstract] [Full Text] [Related]

  • 24. The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections.
    Cortesia C, Lopez GJ, de Waard JH, Takiff HE.
    J Antimicrob Chemother; 2010 Dec 19; 65(12):2574-81. PubMed ID: 20926395
    [Abstract] [Full Text] [Related]

  • 25. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR, Kim MJ, Choi JY, Kim HS, Kang CI, Cho YK, Park DW, Lee HJ, Lee MS, Ko KS.
    J Med Microbiol; 2012 Mar 19; 61(Pt 3):353-360. PubMed ID: 22016557
    [Abstract] [Full Text] [Related]

  • 26. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR, Thamlikitkul V, Silveira FP, Garonzik SM, Tao X, Forrest A, Soo Shin B, Kaye KS, Bulitta JB, Nation RL, Li J, Tsuji BT.
    J Antimicrob Chemother; 2017 May 01; 72(5):1415-1420. PubMed ID: 28333347
    [Abstract] [Full Text] [Related]

  • 27. Impact of material properties in determining quaternary ammonium compound adsorption and wipe product efficacy against biofilms.
    Pascoe MJ, Mandal S, Williams OA, Maillard JY.
    J Hosp Infect; 2022 Aug 01; 126():37-43. PubMed ID: 35427722
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X, Garcia de la Maria C, López-Rojas R, Pachón J, Giralt E, Vila J.
    Clin Microbiol Infect; 2012 Apr 01; 18(4):383-7. PubMed ID: 21672084
    [Abstract] [Full Text] [Related]

  • 29. Two types of colistin heteroresistance in Acinetobacter baumannii isolates.
    Hong YK, Kim H, Ko KS.
    Emerg Microbes Infect; 2020 Dec 01; 9(1):2114-2123. PubMed ID: 32897166
    [Abstract] [Full Text] [Related]

  • 30. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X, Callarisa AE, Gu X, Savage PB, Giralt E, Vila J.
    Int J Antimicrob Agents; 2015 Nov 01; 46(5):568-71. PubMed ID: 26395218
    [Abstract] [Full Text] [Related]

  • 31. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ, Kim JO, Lee H, Yoon EJ, Jeong SH, Yong D, Lee K.
    Diagn Microbiol Infect Dis; 2016 Oct 01; 86(2):184-9. PubMed ID: 27475960
    [Abstract] [Full Text] [Related]

  • 32. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A, Neshani A, Mirhosseini SA, Ghazvini K, Zare H, Sedighian H.
    Microb Pathog; 2021 Jan 01; 150():104700. PubMed ID: 33346078
    [Abstract] [Full Text] [Related]

  • 33. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S, Kim MC, Park SJ, Kim HS, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS, Chong YP.
    Antimicrob Agents Chemother; 2016 Nov 01; 60(11):6774-6779. PubMed ID: 27600048
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A Systematic Review and Quantitative Synthesis of the Efficacy of Quaternary Ammonium Compounds in Disinfesting Nonfungal Plant Pathogens.
    Copes WE, Ojiambo PS.
    Plant Dis; 2023 Oct 01; 107(10):3176-3187. PubMed ID: 36890133
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of disinfectant susceptibility profiles among clinical isolates of Acinetobacter baumannii in Ardabil, Iran.
    Namaki Kheljan M, Hassanzadeh M, Srdari Jabedar M, Mohammadi Gollou A, Ashouri P, Teimourpour R, Arzanlou M.
    Acta Microbiol Immunol Hung; 2023 Dec 07; 70(4):311-317. PubMed ID: 38063878
    [Abstract] [Full Text] [Related]

  • 39. Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.
    Sherman EX, Wozniak JE, Weiss DS.
    Methods Mol Biol; 2019 Dec 07; 1946():39-50. PubMed ID: 30798542
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.